Showing 401 - 420 results of 613 for search '(( 13 1 decrease ) OR ( 10 ((meters decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.17s Refine Results
  1. 401
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407
  8. 408
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413
  14. 414
  15. 415
  16. 416
  17. 417
  18. 418

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Conversely, patients with non-heart failure-related polypharmacy had increased risks of ICU admissions (aOR=1.78, 95% CI: 1.13 – 2.70). ConclusionIn an examination of a database of patients with chronic heart failure, major non-heart failure-related polypharmacy was associated with increased risks in intensive care admissions. …”
    Get full text
    Get full text
    Get full text
  19. 419
  20. 420